Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

11.47 -0.52 (-4.30%)
Streaming Delayed Price Updated: 12:34 PM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,678,760
Open 11.95
Bid (Size) 11.47 (19)
Ask (Size) 11.48 (3)
Prev. Close 11.99
Today's Range 11.46 - 11.96
52wk Range 3.532 - 23.86
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
Don't be too quick to jump on the Wall Street bandwagon. 
Via The Motley Fool
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to... 
Via Benzinga
Exposures COVID-19 Product Safety

Performance

YTD
+128.13%
+128.13%
1 Month
-32.93%
-32.93%
3 Month
-26.04%
-26.04%
6 Month
+108.64%
+108.64%
1 Year
+37.43%
+37.43%

More News

Read More
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
Via Investor's Business Daily
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
Via Benzinga
Topics ETFs
Exposures COVID-19 Product Safety
Looking Into Novavax's Recent Short Interest
Via Benzinga
Market Whales and Their Recent Bets on NVAX Options
Via Benzinga
What's Going On With Novavax Shares Today?
Via Benzinga
Looking Into Novavax's Recent Short Interest
Via Benzinga
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
Via MarketBeat
Exposures COVID-19 Product Safety
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
Via MarketBeat
Exposures COVID-19
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
Via Benzinga
Exposures COVID-19
NVAX Stock Earnings: Novavax Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3
Via Talk Markets
Where Will Novavax Be in 5 Years?
Via The Motley Fool
What's Going On With Novavax (NVAX) Stock?
Via Benzinga
Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat
Via Investor's Business Daily
JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024
Via InvestorPlace
JPMorgan Just Issued a Warning on Novavax (NVAX) Stock
Via InvestorPlace
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stocks Mixed After Job Openings, Consumer Data
Via Talk Markets
Topics Economy
Exposures Interest Rates
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
Via Talk Markets
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.